Women in India are the first in the world to receive new heat-stable carbetocin formulation to prevent excessive bleeding after childbirth
inFerring Pharmaceuticals announced today that Mirjam Mol-Arts, previously Senior Vice President, Global Development, has been appointed to the position of Executive Vice President, Chief Science Officer and Chief Medical Officer.